Home LiteratureArticle Details
PMID: 323358 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Expression of alloantigens LY-5 and LY-6 on cytotoxic effector cells.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 118 ·No. 5 ·1977-05-00 ·Pages 1739-43

Woody JN, Feldmann M, Beverley PC, McKenzie IF

Abstract

With anti-Ly antisera and complement it has been possible to demonstrate that cytotoxic effector cells generated in vitro against allogeneic cells carry the alloantigen Ly-5 and Ly-6. The studies show that antisera directed against the Ly-6 antigens, together with complement, eliminate essentially all of the killer cells, of the appropriate strain, while killing only 50 to 60% of Thy-1+ cells. Anti-Ly-5 antsera and complement lysed 55 to 65% of Thy-1+ cells and killed a significant portion, but not all, of the cytotoxic cells. The later finding was investigated in more detail since it suggested a degree of heterogeneity within the killer cell subpopulation. However, the data did not support that conclusion, at least for allogeneic killer cells.

MeSH Terms
Animals Antilymphocyte Serum/pharmacology Cell Separation Cytotoxicity Tests, Immunologic Immunity, Cellular Immunosorbent Techniques In Vitro Techniques Isoantigens Lymphocytes/immunology Mice Mice, Inbred Strains Phenotype Species Specificity T-Lymphocytes/immunology
Chemicals
Antilymphocyte Serum Isoantigens
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Woody J N
Feldmann M
Beverley P C
McKenzie I F
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1977-05-00
Pages
1739-43
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com